Apexigen, Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Apexigen, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2023.
- Apexigen, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$6.16M, a 24.4% increase year-over-year.
- Apexigen, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$27.8M, a 39.4% increase year-over-year.
- Apexigen, Inc. annual Operating Income (Loss) for 2022 was -$32.7M, a 12.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)